Login
$LIF
$43.93 +$0.00 (0.0%) Close

$LIF SEC Filings

Filed On Filing
13 Nov 2026 144
09 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q3'26 Investor Update Q U A R T E R L Y P R E S E N T A T I O N 9 November 2026 U.S. PT 10 November 2026 AEDT

09 Nov 2026 10-Q
04 Nov 2026 Form 4: Coghlan John Philip, Director

Sold 4,000 shares ($183K)

03 Nov 2026 SCHEDULE 13G/A
15 Oct 2026 Form 4: Prober Charles J., Director

Received 7,930 shares by exercise or conversion ($88.7K) · Sold 7,930 shares ($343K)

13 Oct 2026 144
08 Oct 2026 Form 4: Haro Alex, Director

Received 50,000 shares by exercise or conversion ($127K) · Sold 50,000 shares ($2.07M)

06 Oct 2026 144
06 Oct 2026 SCHEDULE 13G/A
05 Oct 2026 Form 4: Coghlan John Philip, Director

Sold 4,000 shares ($161K)

01 Oct 2026 144
23 Sep 2026 Form 4: Haro Alex, Director

Received 50,000 shares by exercise or conversion ($127K) · Sold 50,000 shares ($2.04M)

21 Sep 2026 144
16 Sep 2026 Form 4: Prober Charles J., Director

Received 7,930 shares by exercise or conversion ($88.7K) · Sold 7,930 shares ($334K)

14 Sep 2026 144
10 Sep 2026 Form 4: Hulls Chris, Director

Gave up 7,545 shares to cover exercise price or tax ($333K)

10 Sep 2026 Form 4: Antonoff Lauren, Director

Gave up 6,291 shares to cover exercise price or tax ($278K)

10 Sep 2026 Form 4: Burke Russell John, Chief Financial Officer

Gave up 5,314 shares to cover exercise price or tax ($235K)

03 Sep 2026 Form 4: Coghlan John Philip, Director

Sold 4,000 shares ($168K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support